Published Date: 03 Mar 2023
FGF21 Inflammation associated with indicators of nutritional status in patients with IBD
Read Full NewsAbdominal and chest pain. Injuries. Breathing difficulty. Infections. Mental health emergencies. Those are some of the most common reasons why people go to the local emergency department.
University of Colorado Cancer Center member Matthew Sikora, Ph.D., is a national leader in research into an understudied subtype of breast cancer that's on the rise in American women, is often more difficult to detect than ...
Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but physical and emotional too. Chemotherapy and radiotherapy remain vital tools, yet they often damage ...
1.
Waiting for a Sharp Increase in Prostate Cancer Cases.
2.
Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?
3.
Global inequalities found in cancer research funding
4.
We don't all need regular skin cancer screening?but you can know your risk and check yourself
5.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
1.
Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy
2.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
3.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
4.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
5.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation